//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Professor of Cancer Virology, University of Leeds. Co-Chair, Independent SAGE
Steve Griffin









Loading...
I and @independentsage.bsky.social advocated kids vax vs SARS2 since day 1. Even when transiently available to u12s, they were sold as a damp squib by those in authority. As vax coverage dwindles, the lack of foresight gets harder to reconcile. #LongCovidKids is a major neglected issue 💔
That dynamic does not apply to most other variants. It could help explain why BA.3.2 has been around for so long and may suggest it has long-term staying power, especially if, beyond its antibody-evasion advantage, it is particularly well adapted to infecting young children. #BA32
This means its primary host population is effectively renewed every four years, with new cohorts of largely immunologically naive children entering the population, aside from maternal antibodies.
BA.3.2 - a "forever" variant? I've always wondered why BA.3.2 has persisted for such a long time. Now we know that it mainly targets the 0-4-year age group, and we know why. Could that explain its persistence?
Taking the idea one step further: Could the establishment of a reservoir in young children- as discussed in my previous post - be one of the routes by which SARS-CoV-2 transitions into endemic circulation?
Finally. BBC News - Meningitis B vaccine to be offered to a million young people www.bbc.co.uk/news/article...